Latest news
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - TradingViewTradingView · Fri, 07 Aug 2026 17:41:00 GMTProthena Corporation PLC reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:38:32 GMTProthena (NASDAQ: PRTA) turns H1 2026 profit on $50M milestone - Stock TitanStock Titan · Thu, 06 Aug 2026 20:20:43 GMTProthena Reports Second Quarter 2026 Financial Results and Business Highlights - Business WireBusiness Wire · Thu, 06 Aug 2026 20:05:00 GMTFMR LLC discloses 13.8% Prothena (PRTA) ownership; key fund holds 6.4% - Stock TitanStock Titan · Thu, 06 Aug 2026 14:40:07 GMTProthena publishes corporate overview presentation on protein-dysregulation drug pipeline - BitgetBitget · Thu, 06 Aug 2026 13:33:51 GMTProthena Corporation PLC (PRTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Tue, 04 Aug 2026 07:00:00 GMTTechnical Reactions to PRTA Trends in Macro Strategies - Stock Traders DailyStock Traders Daily · Sun, 02 Aug 2026 03:10:02 GMT